Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-06-05
1980-04-01
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 260112B, 424 12, 546194, A61K 4300, G01N 3316
Patent
active
041961854
ABSTRACT:
An improved immunoassay for detecting the drug of abuse phencyclidine is described. This immunoassay is characterized in utilizing as reagents (i) an antibody elicited with a novel immunogen comprising 4-[(1-piperidinyl)cyclohexyl] benzoic acid covalently bonded to an immunogenic carrier material through the carboxyl group and (ii) a novel radiolabeled derivative of phencyclidine, namely .sup.125 I N-(4-hydroxy-2-phenylethyl)-4-[1-(1-piperidinyl)cyclohexyl] benzamide.
REFERENCES:
patent: 4000143 (1976-12-01), Dykstra et al.
patent: 4038268 (1977-07-01), Moritz et al.
Kaur et al., J. Med. Chem., vol. 12, 1969, pp. 473-476.
Kaur et al., Theriogenology, vol. 6, Nos. 2-3, 1976, pp. 193-208.
Pearce, Clin. Chem., vol. 22, No. 10, Oct. 1976, pp. 1623-1626.
Focella Antonino
Heveran John E.
Gould George M.
Hoffmann-La Roche Inc.
Isgro William G.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Immunoassay for phencyclidine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoassay for phencyclidine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoassay for phencyclidine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1313888